F+FreeMedSite USMLELearn with clinical reasoning
USMLE Step 1High-yield → advanced clinical decision-making

Question 040 / 40 published

USMLE-STYLE CLINICAL SCENARIODenosumab inhibition of osteoclast differentiation
A 71-year-old woman has postmenopausal osteoporosis with a prior fragility fracture. She begins denosumab therapy after evaluation of calcium and vitamin D status. The drug reduces bone resorption by blocking a ligand that normally binds RANK on osteoclast precursors. Which molecule is directly neutralized?
Select one best answer
Back to block →
← Previous